Amber Bryant Colón is an accomplished businesswoman and healthcare professional with extensive experience in strategy, operations, and management. She is a graduate of the prestigious Yale School of Management, where she earned her Master of Business Administration (MBA) degree. Prior to that, she studied Engineering Sciences at Dartmouth College and Biotechnology at the Thayer School of Engineering at Dartmouth.

Amber is currently serving as the Director of Global Strategy and Operations for Connected Care and Insulins at Eli Lilly and Company. She has held a variety of other roles throughout her career, including Emerging Leader at Crossroads for Kids, Director of US Payer Strategy for Diabetes Connected Care at Eli Lilly and Company, and Senior Analyst at Health Advances. Her past experience also includes positions in brand management, commercial strategy, and integrated care.

As an expert in the healthcare industry, Amber possesses a wealth of knowledge and skills that make her a valuable asset to any organization. She has a passion for improving patient outcomes and is dedicated to developing innovative solutions that benefit both patients and businesses. Her background in biotechnology, engineering, and business makes her a well-rounded professional who is able to approach problems from multiple angles.